Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-09
DOI
10.1038/s41598-019-53999-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The biological effects of the hypolipidaemic drug probucol microcapsules fed daily for 4 weeks, to an insulin-resistant mouse model: potential hypoglycaemic and anti-inflammatory effects
- (2018) Armin Mooranian et al. Drug Delivery and Translational Research
- Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetes
- (2018) Armin Mooranian et al. Artificial Cells Nanomedicine and Biotechnology
- Single-Dose Metformin Enhances Bile Acid–Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes
- (2017) Andreas Brønden et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Innovative Microcapsules for Pancreatic β-Cells Harvested from Mature Double-Transgenic Mice: Cell Imaging, Viability, Induced Glucose-Stimulated Insulin Measurements and Proinflammatory Cytokines Analysis
- (2017) Armin Mooranian et al. PHARMACEUTICAL RESEARCH
- Designing anti-diabetic β-cells microcapsules using polystyrenic sulfonate, polyallylamine, and a tertiary bile acid: Morphology, bioenergetics, and cytokine analysis
- (2016) Armin Mooranian et al. BIOTECHNOLOGY PROGRESS
- Biological Assessments of Encapsulated Pancreatic β-Cells: Their Potential Transplantation in Diabetes
- (2016) Armin Mooranian et al. Cellular and Molecular Bioengineering
- Glucose and lipid effects of the ileal apical sodium-dependent bile acid transporter inhibitor GSK2330672: double-blind randomized trials with type 2 diabetes subjects taking metformin
- (2016) D. J. Nunez et al. DIABETES OBESITY & METABOLISM
- The Influence of Stabilized Deconjugated Ursodeoxycholic Acid on Polymer-Hydrogel System of Transplantable NIT-1 Cells
- (2016) Armin Mooranian et al. PHARMACEUTICAL RESEARCH
- Alginate-deoxycholic Acid Interaction and Its Impact on Pancreatic Β-Cells and Insulin Secretion and Potential Treatment of Type 1 Diabetes
- (2016) Armin Mooranian et al. Journal of Pharmaceutical Innovation
- Role of inflammation in sensory neuropathy in prediabetes or diabetes
- (2015) T. Duksal et al. ACTA NEUROLOGICA SCANDINAVICA
- A comprehensive study of novel microcapsules incorporating gliclazide and a permeation enhancing bile acid: hypoglycemic effect in an animal model of Type-1 diabetes
- (2015) Sangeetha Mathavan et al. DRUG DELIVERY
- Oral Absorption Enhancement of Probucol by PEGylated G5 PAMAM Dendrimer Modified Nanoliposomes
- (2015) Qian Ma et al. MOLECULAR PHARMACEUTICS
- Multicompartmental, multilayered probucol microcapsules for diabetes mellitus: Formulation characterization and effects on production of insulin and inflammation in a pancreatic β-cell line
- (2015) Armin Mooranian et al. Artificial Cells Nanomedicine and Biotechnology
- Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes
- (2015) Rebecca Negrulj et al. Artificial Cells Nanomedicine and Biotechnology
- The effect of a tertiary bile acid, taurocholic acid, on the morphology and physical characteristics of microencapsulated probucol: potential applications in diabetes: a characterization study
- (2015) Armin Mooranian et al. Drug Delivery and Translational Research
- The incorporation of water-soluble gel matrix into bile acid-based microcapsules for the delivery of viable β-cells of the pancreas, in diabetes treatment: biocompatibility and functionality studies
- (2015) Armin Mooranian et al. Drug Delivery and Translational Research
- Probucol Release from Novel Multicompartmental Microcapsules for the Oral Targeted Delivery in Type 2 Diabetes
- (2014) Armin Mooranian et al. AAPS PHARMSCITECH
- Targeting 12-lipoxygenase as a novel strategy to combat the effects of inflammation on beta cells in diabetes
- (2014) Jan A. Ehses et al. DIABETOLOGIA
- Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk
- (2014) Fleur Lien et al. JOURNAL OF CLINICAL INVESTIGATION
- An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations
- (2014) Armin Mooranian et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Directed Self-assembled Nanoparticles of Probucol Improve Oral Delivery: Fabrication, Performance and Correlation
- (2014) Zhiwen Zhang et al. PHARMACEUTICAL RESEARCH
- Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics
- (2014) Armin Mooranian et al. Journal of Pharmaceutical Innovation
- Advanced bile acid-based multi-compartmental microencapsulated pancreatic β-cells integrating a polyelectrolyte-bile acid formulation, for diabetes treatment
- (2014) Armin Mooranian et al. Artificial Cells Nanomedicine and Biotechnology
- Validation of inhibitors of an ABC transporter required to transport lipopolysaccharide to the cell surface in Escherichia coli
- (2013) David J. Sherman et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Nuclear-receptor–mediated regulation of drug– and bile-acid–transporter proteins in gut and liver
- (2013) Jeff L. Staudinger et al. DRUG METABOLISM REVIEWS
- Restoration of the Unfolded Protein Response in Pancreatic Cells Protects Mice Against Type 1 Diabetes
- (2013) F. Engin et al. Science Translational Medicine
- What causes the insulin resistance underlying obesity?
- (2013) Olga T. Hardy et al. Current Opinion in Endocrinology Diabetes and Obesity
- Incretin secretion stimulated by ursodeoxycholic acid in healthy subjects
- (2013) Masanori Murakami et al. SpringerPlus
- Interaction of ABC transport proteins with toxic metals at the level of gene and transport activity in the PLHC-1 fish cell line
- (2012) Camilla Della Torre et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Dose-dependent antiinflammatory effect of ursodeoxycholic acid in experimental colitis
- (2012) Patricia Martínez-Moya et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Restoration of dietary-fat induced blood–brain barrier dysfunction by anti-inflammatory lipid-modulating agents
- (2012) Menuka Pallebage-Gamarallage et al. Lipids in Health and Disease
- Fatty Acids, Obesity, and Insulin Resistance: Time for a Reevaluation
- (2011) F. Karpe et al. DIABETES
- Ursodeoxycholic Acid for Treatment of Fatty Liver Disease and Dyslipidemia in Morbidly Obese Patients
- (2011) Hanns-Ulrich Marschall et al. DIGESTIVE DISEASES
- Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats
- (2011) Hani Al-Salami et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Probucol Suppresses Enterocytic Accumulation of Amyloid-β Induced by Saturated Fat and Cholesterol Feeding
- (2011) Menuka M. Pallebage-Gamarallage et al. LIPIDS
- Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet–fed KK-Ay mice
- (2011) Takuma Tsuchida et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin
- (2010) Sarah J. Hemauer et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats
- (2010) Hani Al-Salami et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Effects of Pioglitazone and Metformin Fixed-Dose Combination Therapy on Cardiovascular Risk Markers of Inflammation and Lipid Profile Compared With Pioglitazone and Metformin Monotherapy in Patients With Type 2 Diabetes
- (2010) Alfonso Perez et al. Journal of Clinical Hypertension
- Lithocholic acid upregulates uPAR and cell invasiveness via MAPK and AP-1 signaling in colon cancer cells
- (2009) Min Kyung Baek et al. CANCER LETTERS
- Bile acids: regulation of apoptosis by ursodeoxycholic acid
- (2009) Joana D. Amaral et al. JOURNAL OF LIPID RESEARCH
- Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics
- (2009) H. Al-Salami et al. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
- Nanoparticle Processing in the Solid State Dramatically Increases the Cell Membrane Permeation of a Cholesterol-Lowering Drug, Probucol
- (2009) Toshiro Fukami et al. MOLECULAR PHARMACEUTICS
- Bile-acid-induced cell injury and protection
- (2009) Maria J Perez et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now